Related Experiment Video
Updated: Sep 22, 2025
06:21
Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
10.6K
A powerful tool to study metabolic reprogramming in pediatric cancers.
Rindert Missiaen1, M Celeste Simon1
1Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, PA, USA.
Med (New York, N.Y.)
|May 19, 2022
Summary
A new intra-operative U13C-glucose infusion method is safe for pediatric cancer patients. This technique reveals cancer-specific metabolic changes, aiding in new treatment strategies for pediatric cancers.
Area of Science:
- Oncology
- Metabolic Engineering
- Medical Diagnostics
Background:
- Pediatric cancers exhibit unique metabolic profiles.
- Understanding these metabolic alterations is crucial for developing targeted therapies.
- Current diagnostic methods may not fully capture dynamic metabolic changes during treatment.
Purpose of the Study:
- To develop and validate an intra-operative metabolic analysis protocol using U13C-glucose.
- To assess the tolerability and safety of the protocol in pediatric cancer patients.
- To identify cancer-type-specific metabolic signatures and their therapeutic implications.
Main Methods:
- Developed an intra-operative infusion protocol using stable isotope-labeled U13C-glucose.
- Administered the infusion during surgical procedures in pediatric cancer patients.
- Analyzed metabolic alterations using advanced analytical techniques.
Main Results:
- The U13C-glucose infusion protocol was well-tolerated in pediatric cancer patients.
- Demonstrated cancer-type-specific metabolic alterations.
- Identified metabolic pathways with potential therapeutic consequences.
Conclusions:
- The developed intra-operative U13C-glucose infusion protocol is a safe and effective tool for pediatric cancer research.
- Findings provide valuable insights into the metabolic landscape of pediatric cancers.
- This approach can guide the design of novel therapeutic strategies for improved patient outcomes.
